[Studies on the stability of antitumor protein, neocarzinostatin. II. Stability of injection of neocarzinostatin (author's transl)].
D000818:Animals; D000903:Antibiotics, Antineoplastic; D001202:Ascitic Fluid / Q000378:metabolism; D001205:Ascorbic Acid; D004304:Dosage Forms; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D007267:Injections; D051381:Rats; D012505:Sarcina / Q000187:drug effects; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D012964:Sodium; D012996:Solutions; D013696:Temperature; D013890:Thiourea; D013997:Time Factors; D014508:Urea; D014867:Water; D009353:Zinostatin / Q000494:pharmacology / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D004304:Dosage Forms; D012996:Solutions; D014867:Water; D014508:Urea; D009353:Zinostatin; D012964:Sodium; D013890:Thiourea; D001205:Ascorbic Acid